We are live on
!
Find out more
Cambridge Investment Research Advisors Portfolio holdings
AUM
$44.6B
1-Year Est. Return
28.94%
This Fund
S&P 500
This Quarter
Est. Return
+8.61%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$14.8B
AUM Growth
+$1.53B
(+12%)
Cap. Flow
+$575M
Cap. Flow
% of AUM
3.88%
Top 10 Holdings %
Top 10 Hldgs %
20.47%
Holding
2,662
New
208
Increased
1,251
Reduced
990
Closed
149
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$56.7M |
| 2 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$43.4M |
| 3 |
Vanguard Extended Market ETF
VXF
|
+$41.1M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$39.4M |
| 5 |
Apple
AAPL
|
+$35.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
C.H. Robinson
CHRW
|
+$26.2M |
| 2 |
Vanguard Short-Term Treasury ETF
VGSH
|
+$25.5M |
| 3 |
Pacer Trendpilot US Large Cap ETF
PTLC
|
+$20.6M |
| 4 |
Schwab US Large-Cap Growth ETF
SCHG
|
+$18.6M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$15M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.79% |
| 2 | Consumer Discretionary | 5% |
| 3 | Healthcare | 4.52% |
| 4 | Financials | 4.2% |
| 5 | Communication Services | 3.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1301
Robert Half
RHI
$4.48B
| $817K | 0.01% |
15,428
+31
| +0.2% | +$1.65K |
|
1302
First Trust Mid Cap Growth AlphaDEX Fund
FNY
$606M
| $816K | 0.01% |
15,246
-1,754
| -10% | -$90.3K |
|
1303
Enphase Energy
ENPH
$5.39B
| $815K | 0.01% |
+9,865
| New | +$661K |
|
1304
Best Buy
BBY
$18B
| $809K | 0.01% |
7,267
+512
| +8% | +$52.4K |
|
1305
Charter Communications
CHTR
$18.7B
| $809K | 0.01% |
1,296
-15
| -1% | -$8.85K |
|
1306
WisdomTree US SmallCap Earnings Fund
EES
$736M
| $809K | 0.01% |
27,079
-79,008
| -74% | -$2.38M |
|
1307
Hasbro
HAS
$13.6B
| $808K | 0.01% |
9,766
-422
| -4% | -$32.7K |
|
1308
Nutrien
NTR
$32.2B
| $807K | 0.01% |
20,614
+3,785
| +22% | +$138K |
|
1309
iShares Genomics Immunology and Healthcare ETF
IDNA
$208M
| $804K | 0.01% |
20,636
+4,892
| +31% | +$188K |
|
|
IBMM
1310
DELISTED
iShares iBonds Dec 2024 Term Muni Bond ETF
IBMM
| $804K | 0.01% |
29,661
+9,241
| +45% | +$251K |
|
1311
Cleveland-Cliffs
CLF
$6.93B
| $803K | 0.01% |
125,025
+6,533
| +6% | +$39.3K |
|
1312
First Trust Ultra Short Duration Municipal ETF
FUMB
$248M
| $803K | 0.01% |
39,880
+8,783
| +28% | +$177K |
|
|
BAND
1313
Bandwidth Inc
BAND
$1.74B
| $801K | 0.01% |
4,588
+1,619
| +55% | +$240K |
|
1314
Philips
PHG
$26.8B
| $801K | 0.01% |
20,960
+8,591
| +69% | +$345K |
|
1315
PIMCO Intermediate Municipal Bond Active Exchange-Traded Fund
MUNI
$3.12B
| $799K | 0.01% |
14,223
-1,978
| -12% | -$111K |
|
1316
Opendoor
OPEN
$3.54B
| $798K | 0.01% |
+43,442
| New | +$519K |
|
1317
iShares MSCI Germany ETF
EWG
$1.67B
| $796K | 0.01% |
27,339
-544
| -2% | -$16K |
|
|
CONE
1318
DELISTED
CyrusOne Inc Common Stock
CONE
| $796K | 0.01% |
11,373
-25
| -0.2% | -$1.96K |
|
1319
Churchill Downs
CHDN
$6.2B
| $794K | 0.01% |
9,698
-2,258
| -19% | -$175K |
|
1320
NovoCure
NVCR
$2.02B
| $794K | 0.01% |
7,134
+449
| +7% | +$35.9K |
|
1321
RH
RH
$3.4B
| $792K | 0.01% |
2,071
+90
| +5% | +$28.4K |
|
|
BCPC
1322
Balchem Corp
BCPC
$5.65B
| $792K | 0.01% |
8,112
+803
| +11% | +$78.7K |
|
1323
Nuveen Enhanced Yield US Aggregate Bond ETF
NUAG
$96.8M
| $787K | 0.01% |
30,656
-31,931
| -51% | -$825K |
|
|
AWF
1324
AllianceBernstein Global High Income Fund
AWF
$878M
| $785K | 0.01% |
74,688
-23,656
| -24% | -$251K |
|
1325
Unum
UNM
$14.7B
| $783K | 0.01% |
46,517
+31,190
| +203% | +$555K |
|
Similar funds
LP
HF
RIM
Cambridge Investment Research Advisors's Q3 2020 Portfolio in Review
As of Q3 2020, Cambridge Investment Research Advisors held 2,662 positions worth $14.8B, up 12% from $13.3B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Cambridge Investment Research Advisors deployed $575M of net new capital in Q3 2020, opening 208 new positions and adding to 1,251 existing holdings. Its largest new stake was Invesco Building & Construction ETF: 187,041 shares worth $6.78M.
By sector, the portfolio is most concentrated in Technology at 9.8% of assets, up from 9% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was C.H. Robinson, an estimated $26.2M trimmed.
- Cambridge Investment Research Advisors's largest Q3 2020 buy was Invesco Building & Construction ETF: 187,041 shares worth $6.78M.
- Cambridge Investment Research Advisors added most to Bristol-Myers Squibb in Q3 2020, an estimated $56.7M increase.
- Cambridge Investment Research Advisors's biggest Q3 2020 reduction was C.H. Robinson, cutting an estimated $26.2M.
- Cambridge Investment Research Advisors fully exited WisdomTree International ESG Fund in Q3 2020, selling an estimated $11.4M.
- Cambridge Investment Research Advisors's ten largest holdings make up 20% of its $14.8B portfolio in Q3 2020.
- Cambridge Investment Research Advisors opened 208 new positions and closed 149 in Q3 2020.
- Cambridge Investment Research Advisors's portfolio value rose 12% quarter-over-quarter to $14.8B.
Based on Cambridge Investment Research Advisors's 13F filing for Q3 2020, filed 29 Oct 2020.